Welcome to CDC stacks | High-level ciprofloxacin resistance in Neisseria gonorrhoeae: first report from Israel. - 15074 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
High-level ciprofloxacin resistance in Neisseria gonorrhoeae: first report from Israel.
  • Published Date:
    2001 Jan-Feb
  • Source:
    Emerg Infect Dis. 7(1):158-159.
Filetype[PDF-40.28 KB]


No Related Documents.
You May Also Like:
  1. An unusual bacterium causing a brain abscess.
    Personal Author:
    Atapattu, D. N.; Jayawickrama, D. P.; Thevanesam, V.;
    Published:
    2001 Jan-Feb
    Source:
    Emerg Infect Dis. 7(1):159-160.
    File Type:
    Filetype[PDF - 40.40 KB]
  2. Antimicrobial Drug Prescription and Neisseria gonorrhoeae Susceptibility, United States, 2005–2013
    Personal Author:
    Kirkcaldy, Robert D.; Bartoces, Monina G.; Soge, Olusegun O.; Riedel, Stefan; Kubin, Grace; Del Rio, Carlos; Papp, John R.; Hook, Edward W.; Hicks, Lauri A.;
    Published:
    Oct 2017
    Source:
    Emerg Infect Dis. 23(10):1657-1663.
    Description:
    We investigated whether outpatient antimicrobial drug prescribing is associated with Neisseria gonorrhoeae antimicrobial drug susceptibility in the United States. Using susceptibility data from the Gonococcal Isolate Surveillance Project during 2005-...
    File Type:
    Filetype[PDF - 455.26 KB]
  3. Drug-resistant Neisseria gonorrhoeae in Michigan
    Personal Author:
    Macomber, Kathryn E.; Boehme, Martha S.; Rudrik, James T.; Ganoczy, Dara; Crandell-Alden, Erin; Schneider, William A.; Somsel, Patricia A.;
    Published:
    Jul 2005
    Source:
    Emerg Infect Dis. 11(7):1009-1015.
    Description:
    The increasing prevalence of quinolone-resistant Neisseria gonorrhoeae (QRNG) in the United States is a cause for concern. Detecting resistance is complicated by the widespread use of molecular tests that do not provide isolates for susceptibility te...
    File Type:
    Filetype[PDF - 144.99 KB]
  4. Gonococcal isolate surveillance program (GISP) protocol
    Personal Author:
    Kirkcaldy, Robert D.; Torrone, Elizabeth; Papp, John R.;
    Corporate Author:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of STD Prevention.
    Published:
    May 2016
    Description:
    The treatment and control of Neisseria gonorrhoeae infections have been complicated by the organism’s ability to acquire antimicrobial resistance. The increasing prevalence of strains with plasmid-mediated resistance to penicillin (PPNG) prompted t...
    File Type:
    Filetype[PDF - 781.02 KB]
  5. Neisseria gonorrhoeae antimicrobial susceptibility surveillance — the Gonococcal Isolate Surveillance Project, 27 sites, United States, 2014
    Personal Author:
    Kirkcaldy, Robert D.; Harvey, Alesia; Papp, John R.; Del Rio, Carlos; Soge, Olusegun O.; Holmes, King K.; Hook, Edward W.; Kubin, Grace; Riedel, Stefan; Zenilman, Jonathan M.; Pettus, Kevin; Sanders, Tremeka; Sharpe, Samera; Torrone, Elizabeth;
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.); National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of STD Prevention.;
    Published:
    July 15, 2016
    Series:
    MMWR. Surveillance summaries : Morbidity and mortality weekly report. Surveillance summaries ; v. 65, no. SS-7
    Description:
    Problem/Condition: Gonorrhea is the second most commonly reported notifiable disease in the United States; 350,062 gonorrhea cases were reported in 2014. Sexually transmitted infections caused by Neisseria gonorrhoeae are a cause of pelvic inflammato...
    File Type:
    Filetype[PDF - 505.71 KB]